Assessment of HER2 status in adenocarcinomas of the stomach or gastroesophageal junction in a Western population.

Nieves Martínez Lago,Maria-Elena Padín-Iruegas,Ihab Abdulkader,Dora Insua Santamaria,Juan Jose Carrera,José Ramón Antúnez López,Rafael Lopez

Assessment of HER2 status in adenocarcinomas of the stomach or gastroesophageal junction in a Western population.

2017

Nieves Martínez Lago
Maria-Elena Padín-Iruegas
Ihab Abdulkader
Dora Insua Santamaria
Juan Jose Carrera
José Ramón Antúnez López
Rafael Lopez

e15548Background: HER2 status is a predictive biomarker to response to trastuzumab in metastatic adenocarcinomas of the stomach our gastroesophageal junction. However, relatively little is known ab...

Keywords:

Stomach
Gastroesophageal Junction
Population
Pathology
Medicine
predictive biomarker
Gastroenterology
Internal medicine
Trastuzumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations